Early intervention with biologic therapy in Crohn´s disease: how early is early?

Abstract

Starting anti-TNF therapy within the first 24 months after diagnosis was associated with a low rate of CD-related complications and high rates of clinical and endoscopic remission, although we found no differences with earlier initiation within this window of opportunity.